Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Report in relation to renaming Herzog Park set to be withdrawn - 2Scientists find evidence that an asteroid contains tryptophan
- 3How HIV/AIDS got its name − the words Americans used for the crisis were steeped in science, stigma and religious language
- 46 Agreeable Earphones To Wear
- 56 Fun Urban areas For Seniors To Travel
- Getting through a Lifelong Change: Individual Examples of overcoming adversity
- Manual for Individual budget Rudiments for Amateurs
- Building a Flourishing Business: Illustrations from Business people
- 5 Signs Now is the ideal time to Update Your Android Telephone: When to Take the Action
- Black Friday Paramount+ deal: Save 50% and stream these buzzy Taylor Sheridan shows
- Ukraine demands army of 800,000 under peace plan
- 5 VIP Voice Exhibitions in Energized Movies
- Investigating the Financial History of the World: A Succinct Outline
- Figure out How to Use the Experience of a Fender bender Legal counselor for Your Potential benefit
